In Italy, for years, there has been an ’empty cradle alarm’, and the Covid-19 pandemic has worsened the situation. In a society undergoing a profound crisis of ‘reproductivity’, reproductive medicine and medically assisted procreation are increasingly the subject of great expectations: from science, in its broadest sense of the term, an answer capable of accompanying and supporting the ‘reproductive well-being’, considering the important contribution of Pma techniques. Starting from these premises, the conference entitled “Current affairs and projects for reproductive medicine and Pma”, scheduled for October 16 in Rome, at Villa Blanc, organized on the occasion of the 25 years of activity of the Italian Center for Assisted Procreation (Cipa ), which since its foundation has focused on a multidisciplinary approach to couple infertility.
The conference will be attended by experts in the sector, who in Italy have written the history of Pma, including Ettore Cittadini, Giuseppe Benagiano, Luca Gianaroli, just to name a few, with whom the aspects relating to the multidisciplinarity of the couple’s approach will be explored. infertile. One modality, that of the Cipa – center directed by Michele Ermini – “in which specialists from various disciplines such as gynecology, andrology, endocrinology, biology, obstetrics and psychology relate to guarantee the infertile couple a broad clinical vision of the issues and criticalities, for a better diagnostic and therapeutic personalization of the assisted reproduction process “, reads a note.
The objective of the event, therefore, is to “promote a debate on the validity and relevance of this organizational model which over the years has achieved excellent clinical-scientific results and a proven experience in knowing how to welcome couples in their complexity of women and men”. The meeting “offers an opportunity for an analysis of the evolution of knowledge in the gynecological and andrological fields that have led to the current diagnostic investigations and therapeutic strategies. At the same time, the rapid progress of knowledge of the biology of reproduction has allowed a development, in the clinical embryology laboratory, of new highly innovative biotechnological applications which, together with the implementation and optimization of procedural and management requirements – concludes the note – have improved performance not only in terms of ‘babies in arms’, but also in safety of the procedures “.